Navigation Links
Study Shows Gradual Addition of NovoLog® at Mealtime Can Reduce A1c in Type 2 Diabetes Patients
Date:6/28/2010

outlined in the study, can be equally effective, whether using a more intuitive approach (like SimpleSTEP) or one with more frequent, precise measurements of blood sugar levels (like ExtraSTEP), for intensifying therapy in patients with type 2 diabetes to lower A1c levels.  

"A significant challenge for physicians treating patients with type 2 diabetes is figuring out how to introduce a meal-time insulin when basal insulin with or without oral medications is no longer enough to keep blood sugar levels stable," said Luigi Meneghini, M.D., M.B.A., lead investigator in the STEPwise™ trial, Professor of Clinical Medicine at the University of Miami Miller School of Medicine. "With the SimpleSTEP and ExtraSTEP algorithms, we have identified an approach for how to gradually introduce and intensify doses of NovoLog® at mealtimes in patients who increasingly need glucose control as their diabetes progresses."

More details of the study will be presented at the American Diabetes Association's Scientific Sessions in Orlando, FL on Monday, June 28 during Poster Session III, 12:00-2:00  p.m. in the Orange County Convention Center, Hall C.

About the STEPwise Trial(1)

The trial involved 296 patients, at an average age of 58 and mean A1c of 8.8% on basal insulin and oral medications. The primary efficacy endpoint was HbA1c after 36 weeks of treatment. Treatment was given with Levemir® FlexPen® once daily in combination with NovoLog® FlexPen® one to three times daily, before meals, with the dose adjusted individually based on defined titration guidelines developed for the study.

  • The mean
    '/>"/>

SOURCE Novo Nordisk
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Tolerx Presents Baseline Data from DEFEND-1 Study Validating C-Peptide as Critical Clinical Measure for New-Onset Type 1 Diabetes
2. PARI Pharmas Altera Delivers Gileads Cayston in Head-to-Head Study With Tobramycin Inhalation Solution
3. DURECT Reports Data From European Phase IIb Hysterectomy Study of POSIDUR(TM) (SABER(TM)-Bupivacaine)
4. Trius Therapeutics Obtains Special Protocol Assessment With FDA for Phase 3 Study of Torezolid Phosphate
5. National Eye Institute Launches Ancillary Study to AREDS2 With ForeseeHome(TM) AMD Monitor
6. Benchmarking Study Reveals What Bio-Pharma Companies Need to Know to Achieve Successful Integration after an Acquisition or Merger
7. Karmanos Cancer Institute Researchers Study Bisphosphonates and Their Affect on Early Stage Breast Cancer
8. Mach 7 Technologies Rolls Out Keystone Study Segmentation, Rapid Migration and Import - Export Utilities
9. Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors
10. Highmark Study Shows Integrated Medical and Pharmacy Benefits Lower Costs, Promote Better Health
11. Mach 7 Technologies Provides Optimized CT and MR Study Segmenting Software to Massachusetts General Hospital Imaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/5hkm2f/medical_oxygen ) has ... - Global Strategic Business Report" report to their ... for Medical Oxygen Systems in US$ Thousands by the ... & Regulators, and Oxygen Conserving Devices. The report provides ... , Japan , ...
(Date:4/17/2015)... 17, 2015   IBA Molecular, a global ... today that it has signed a definitive agreement to ... (IBAM NA), to Illinois Health and Science (IHS). Under IHS ... independent company headquartered in Dulles, Virginia ... of new product and footprint synergies. IBA Molecular is ...
(Date:4/17/2015)... TAIPEI , April 17, 2015 TWi ... fully-owned subsidiary, TWi Pharmaceuticals USA , ... in the United States.  It has been in close ... wholesalers and expects to have its own label specialty ... soon in the U.S. pharma market. According ...
Breaking Medicine Technology:Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2Health Care System to Acquire IBA Molecular North America 2Health Care System to Acquire IBA Molecular North America 3
... and Safety of Combination Drug Therapies -, ... Life,Sciences, Inc. (Nasdaq: CALP ) today ... & Services (CDAS). These new services,will help ... therapies,and identify potentially harmful combinations before therapies ...
... WILMINGTON, Del., Nov. 30 AstraZeneca (NYSE:,AZN) announced ... in the,ZEST (ZACTIMA Efficacy Study versus Tarceva) study, ... investigational once-daily oral anti-cancer drug,vandetanib. Data from the ... a randomized, double-blind, multi-center Phase III study to,assess ...
Cached Medicine Technology:Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds 2AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer 2
(Date:4/17/2015)... WA (PRWEB) April 17, 2015 ERGO-Pedic ... cushions is introducing two new products to help a ... low back pain relief are the second most common ... our first product, designed specifically to help relieve sitting ... Comfort Cushion, and thousands of happy customers later, we ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Alcohol and ... Dependence (NCADD) notes that drinking and driving has been ... At the same time, the link between alcohol and ... domestic abuse and violence and sexual assault, and their ... to the NCADD, 5.3 million adults in America were ...
(Date:4/17/2015)... 2015 “We have seen healing, a lot ... and present,” said Chaplain Shawn Kafader of Friendship Village. ... they had anything to contribute have created beautiful pieces of ... new art therapy program that was launched to benefit residents ... from School of the Art Institute in Chicago, worked as ...
(Date:4/17/2015)... D.C. (PRWEB) April 17, 2015 In ... issued the following statement: “On Wednesday April 15th, the ... and adopted a resolution recognizing the Armenian Genocide, “paying ... memory of the one-and-a-half million innocent Armenian victims who ... Christians (IDC) extols the EU for this timely and ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Representatives Jim ... Diagnoses and Treatment Act HR 1849 in congress on ... rates and treatment for patients with the genetic disease. ... the past, would be the first to create a ... appropriate treatment of hereditary hemorrhagic telangiectasia. This would effectively ...
Breaking Medicine News(10 mins):Health News:Seat Cushion Company Credits Customer Driven Design For Two New Products 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3Health News:Healing At Friendship Village Due To Art Therapy 2Health News:In Defense of Christians Condemns Armenian Genocide 2Health News:In Defense of Christians Condemns Armenian Genocide 3Health News:House Representatives Introduce Bill to Fight Genetic Disease 2
... which men are at increased risk, scientists say , MONDAY, ... identified key gene variants tied to an increased risk of ... step toward understanding which men are at high risk for ... not been any clear genetic risk factors that can account ...
... 1 Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, ... the companies have begun enrolling patients in an international ... patients with non-squamous non-small cell lung cancer (NSCLC) who ... , "Nexavar has proven efficacy in liver cancer and ...
... Two of the nation,s most rapidly growing retained physician search ... Inc., Atlanta, GA, have agreed to merge their operations under ... not disclosed. , , Crutchfield Capital Corporation served ... "Successful mergers are built upon cultural fit, the integrity of ...
... and response at national and local level , , ... $1 million over the next three years through the Ryder ... response efforts, making it the newest member of the American ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090108/RedCrossLOGO ) , ...
... on Rebuilding Revenue Base While Stabilizing Costs--, ... /PRNewswire-FirstCall/ - Vancouver, BC, Canada - Neovasc Inc. (TSXV: NVC), ... 31, 2009. , "The first quarter continued to show financial ... Neovasc on our most promising growth areas," said Alexei Marko, ...
... clinical recommendations encourage cardiologists to examine the mouth and periodontists ... June 1 Cardiovascular disease, the leading killer of men ... health issue contributing to 2,400 deaths each day. Periodontal disease, ... that support the teeth affects nearly 75 percent of Americans ...
Cached Medicine News:Health News:Researchers Spot Genes Linked to Testicular Cancer 2Health News:Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer 2Health News:Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer 3Health News:Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer 4Health News:Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer 5Health News:Unprecedented Merger Occurs in Retained Physician Search Industry 2Health News:Unprecedented Merger Occurs in Retained Physician Search Industry 3Health News:Ryder System, Inc. Joins the American Red Cross Annual Disaster Giving Program 2Health News:Ryder System, Inc. Joins the American Red Cross Annual Disaster Giving Program 3Health News:Ryder System, Inc. Joins the American Red Cross Annual Disaster Giving Program 4Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 2Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 3Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 4Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 5Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 6Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 7Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 8Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 9Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 10Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 11Health News:Healthy Gums and a Healthy Heart: The Perio-Cardio Connection 2Health News:Healthy Gums and a Healthy Heart: The Perio-Cardio Connection 3Health News:Healthy Gums and a Healthy Heart: The Perio-Cardio Connection 4
... biopsies of soft tissue. Lightweight and compact, ... control. Precise, rapid firing mechanism provides intact ... easy penetration into the specimen with less ... of cannula helps assure an intact tissue ...
... The Bard EXPRESS Seeding Cartridge System is ... delivering radioactive seeds and spacers into a ... Each cartridge has a(n): outer radiation safety ... synthetic absorbable spacers, integrally molded fitting that ...
... very easy to use Ambulatory Urodynamic recorder ... with practising urologists as an invaluable aid ... dysfunctions. The system offers the possibility to ... a natural bladder filling, extented over a ...
A compact mobile System Cart gives mobility within your department. The cart accomodates the Uromac Median data processor, desktop computer, printer and provides stowage space. Patient related transd...
Medicine Products: